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Abstract: Cancer is a common chronic disease all over the world, which will cause serious health burden. At present,
the debate about the role of intestinal flora in the prevention and control of cancer has always existed. Therefore,
researchers should pay close attention to the impact of intestinal flora on several cancers (such as colon cancer, liver
cancer and breast cancer). In addition, it is reported that intestinal flora may also affect the efficacy of cancer
chemotherapy and immunotherapy. This paper introduces some energy research results to help clear the
relationship between intestinal flora and cancer, even cancer micro environment. It can help clarify the mist of cancer
and gut microbiota, let those little creatures to serve the progress of improving mankind living condition and of health
and medicine.
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Foundings:
1. Preclinical study on the treatment of rectal cancer
with Chinese medicine "Ehuang Enema"
2. Effects of Ehuang enema on intestinal flora and
intestinal mucosal barrier function in rats with rectal
cancer by high throughput sequencing
3. Study on the effect of aspirin on intestinal flora of
rats by high throughput sequencing
1. Introduction
Colorectal cancer is one of the most common
malignant tumors in the digestive tract and its etiology
has not been fully elucidated[1]. Intestinal flora plays an
important role in the pathogenesis of colorectal
cancer, but its mechanism is unknown. The number of
intestinal flora is 10 times that of human eukaryotic cells,
150 times that of the human genome, with a total of more
than 100 trillion and more than 1000 species, of which
anaerobic bacteria account for the vast majority [2] .
Physiologically, the intestinal flora maintains relative
homeostasis and interacts with the host. It plays an
important role in nutrition, resisting pathogen invasion
and promoting and maintaining normal immune function.
When the intestinal flora is in equilibrium, the digestion,
metabolism and immune system of the human body are
in equilibrium. When the balance of intestinal flora is
destroyed by various factors inside and outside the body
and exceeds the regulating ability of the human body, it
will affect the normal physiological function of the
human body and lead to the occurrence of disease when
it is serious. Intestinal microecology with the highest
abundance and largest number of bacteria in the digestive
tract is closely related to inflammatory bowel disease,
colon polyps and colorectal cancer. Homeostasis is
destroyed, which can lead to intestinal flora imbalance,
and then induce colon cancer. But the mechanism is not
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very clear. The main ones reported are: inducing chronic
inflammation, synthesizing biotoxins to hinder intestinal
epithelial cell cycle regulation, producing toxic
metabolites, activating carcinogens such as heterocyclic
amines. Research suggests that in the case of human
intestinal flora disorder, some metabolic components
cause inflammation by binding to receptors, which
stimulates the secretion of inflammatory factors, and
other reaction, leading to colon cancer.
The dominant bacteria in coliform are pseudomonas,
snail, verruca microbe, clostridium, prevo, lactic
acid bacteria, etc[3]. There are obvious differences in
intestinal flora between patients with straight colon
cancer and normal people. The current study found that
the structure of intestinal flora in patients with colorectal
cancer has changed greatly compared with those in
health. Enterobacteria such as bacteroides,
clostridium, bacteroides fragilis, enterococcus faecalis,
streptococcus mutans and so on are associated with the
development of colorectal cancer[4]. Scanlan et al[5]
found that in colorectal cancer patients and adenomatous
polyposis patients, the flora and their metabolites
changed significantly, among which C. coccoides
subgroups and clostridium leptum increased significantly.
Sobhani et al[6] found that bacteroides and prevotella in
the feces of colorectal cancer patients were higher than
those of healthy people. Tingting Wang[7] and Na Wu[8]
found that bacteroides, enterococcus, shigel, escherichia,
streptococcus, klebsiella and pepso streptococcus were
significantly increased in fecal flora of patients with
colorectal cancer; However, the number of trichiaceae
(Lach-nospiraceae), faecalibacterium and roseburia
producing butyrate decreased significantly.
2. Intestinal microflora can inhibit
and promote the occurrence of
colon cancer, which is mainly
related to the specific types of
microflora
Probiotics such as lactobaci llus
and bifidobacterium can inhibit the occurrence of colon
cancer. Lactobacillus can induce the production of many
cytokines, including IL-12, TNF - α, etc[9]. The known
physiological functions of lactobacilli are: to prevent the
invasion and colonization of the intestinal tract by
pathogenic bacteria, to maintain the micro
ecological balance of the intestinal tract, to prevent and
inhibit the occurrence of tumors, to enhance the
immunity of the body, to promote digestion, to reduce
cholesterol, to inhibit the production of endotoxin, to
delay aging and anti radiation, etc. Bifidobacterium is the
most numerous probiotics in the intestinal tract.
Experiments show that bifidobacterium can enhance the
expression of bax, which can induce the apoptosis of
cancer cells and prevent the occurrence of colon
cancer by down regulating the expression of bcl-2. In
addition, as the ligand of toll like receptor, the
phospholipid wall on its surface can activate the natural
immune response and induce apoptosis of tumor cells,
which has antitumor effect[10].
As opposed to probiotics, harmful bacteria are a
general term for bacteria that can cause disease in the
host. The intestinal bacteria that cause colon cancer are
streptococcus (streptococcus), enterococcus faecalis
(ente-rococcus faecalis), enterotoxin producing bacteria
(enteroto-xigenic bacteroides fragilis) and so on.
Abdulamir et al[11] found that after streptococcus
infection in mice, the bacteria over expressed flagellin,
which was beneficial to colonize the bacteria in tumor
tissues, and the bacteria promoted the high expression of
inflammatory-related signaling pathways in mouse
intestinal epithelial cells, including the high expression
of cyclooxygenase-2 (COX-2), which triggered intestinal
inflammation. Through high-throughput sequencing
technology, the fecal samples and intestinal cavity
microbes of colon cancer patients and normal people
were analyzed and compared, and it was found that the
number of digestive streptococcus in the excreta of colon
cancer patients increased compared with that of healthy
people[12-15].
Wang et al[16] confirmed from animal experiments
that some enterococcus faecalis can produce superoxide
anion, which induces colon cancer. IL-10 knockout mice
were infected with enterococcus faecalis which could
produce superoxide anion in the experimental group and
in the control group with enterococcus faecalis which did
not produce superoxide anion IL-10 knockout mice.
Experimental mice showed intestinal inflammation,
DNA injury and colon cancer. The mice in the control
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group only caused enteritis and had no tumor.
Enterococcus faecalis-induced colon cancer has been
shown to be a diffusive chromosomal breaker (e.g.
4-hydroxy-2-non, 4-h by inducing mucosal macrophages
ydroxynon-2-enal), which mediated DNA damage
through bystander effects.
For example, bacteroides fragilis can secrete a kind
of bacteroidin fragilis, which can cause DNA damage of
colon epithelial cells. By activating the signal pathways
of Wnt, NF-κ B, STAT3, and so on, it can cause the
inflammatory reaction of intestinal epithelium and
promote colon cancer. The formation of intestinal
microflora through the influence of inflammatory
microenvironment leads to the imbalance of intestinal
microflora in colon cancer, which leads to the conditional
pathogenicity, the increase of mucus permeability, the
migration of bacteria and the activation of innate
immune system[17]. It can cause inflammatory cells to
secrete a large number of inflammatory factors and form
intestinal inflammation microenvironment together with
toxic metabolites of bacteria. Long-term repeated
intestinal inflammation is easy to induce mutation of
intestinal epithelial cells with generating malignant
proliferation, which causes tumors. At present, there are
two theories about the promotion of inflammation by
intestinal flora leading to colon cancer: alpha bug theory
and driver passenger theory.
In alpha bug model, enterotoxin fragilis (ETBF)
was used as an example. ETBF was implanted on the
surface of colon mucosa to secrete fragile bacteroidin
(BFT). It changed the structure of colon epithelial cells
and mucosal immune function and finally led to the
formation of colon cancer. It has been found that BFT
can change the structure and function of colonic
epithelial cells rapidly, including destroying tumor
suppressor protein, e-cadherin and cadherin-e. These
protein molecules can inhibit the formation of colonic
tumors[18-19]. The decomposition of cadherin-e increases
the permeability of colonic epithelial cells, which is
the beginning of tumor development. Due to the release
of cytokines, BFT can activate the transcription factor
NF-κ B and promote the synthesis and secretion of
inflammatory cytokines by colonic epithelial cells.
According to the theory of alpha bug, ETBF can directly
lead to precancerous lesions of colon mucosa, and
change the mucosal immune function and the structure of
other intestinal flora can further promote the occurrence
of colon cancer. Driver passenger model thinks that
driver bacteria is the intestinal bacteria that may cause
tumor, while passenger is the bacteria that has existed in
the intestinal tract before. First of all, the bacteria in the
intestinal driver cause caking the DNA damage of
intestinal epithelial cells is the initial stage of colon
cancer. Secondly, it induces the change of intestinal
microenvironment. Passenger has a competitive
advantage, surpassing driver in colon cancer and in
quantity, and driver may disappear in tumor. According
to the driver passenger theory, first of all, the
colonization of driver bacteria in the colonic mucosa
leads to the continuous inflammatory response of the
mucosa, which leads to the precancerous lesions of the
colonic mucosa by promoting the proliferation of colonic
epithelial cells and producing DNA damage substances.
With the accumulation of DNA damage material, the
colonic epithelial cells mutated, and then changed from
adenomatoid to adenocarcinoma. Whether probiotics can
inhibit colon tumor tissue and whether passenger bacteria
can promote the development of colon tumor tissue need
further study. In a word, driver bacteria and
passenger bacteria have different relations with colon
tumor tissue and play different roles in the development
of colon tumor.
Although some specific microflora will increase the
risk of cancer, some beneficial intestinal bacteria can
prevent various cancers by transforming phytochemicals
into bioactive metabolites and fermenting dietary fiber
into SCFAs, thus maintaining the integrity of intestinal
mucosa and immune system. In addition, intestinal flora
can affect the extragastrointestinal tissues by affecting
the level of estrogen, that is, the risk of breast cancer. In
addition, the potential mechanism of the
interaction between beneficial flora and anticancer effect
is still worth further exploration. On the other hand,
harmful intestinal flora can be reduced or eliminated to
maintain the homeostasis of intestinal flora. In general,
intestinal flora may be an important mediator of diet
cancer association, which suggests that we should go
further to conduct the relationship between intestinal and
cancers[20].
In the past, the study of intestinal microorganisms
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mainly depended on the traditional pure culture
technology of microbial separation. When the method
was used to restore the microflora in the laboratory, the
amount of information obtained by anaerobic
microorganisms was limited. In the past few years,
researchers have studied the methods of fluorescence in
situ hybridization, terminal restriction fragment length
polymorphism (PCR), denaturing gradient gel
electrophoresis (PGGE), biochip, and so on. For example,
at a loss what to do with the detection of the
dominant bacteria in the intestine, denaturing gradient
gel electrophoresis can only detect the trace
microorganisms, but the sensitivity is low. Fluorescence
in situ hybridization technology must rely on the
specificity of oligonucleotide probes, only detect the
known bacteria but not identify the unknown
microorganisms. It can verify the known, can not explore
the unknown, and has defects in the judgment of
microbial abundance. With the rapid development of
detection technology and the maturity and promotion of
the second generation sequencing technology, at present,
high-throughput sequencing technology is mainly used to
detect intestinal microorganisms. High throughput
sequencing technology is a revolutionary change of
traditional sequencing. It can sequence hundreds of
thousands to millions of DNAmolecules at a time. At the
same time, high throughput sequencing makes it possible
to analyze the transcriptome and genome of a species in
a detailed and comprehensive way, so it is also called
deep sequencing. High throughput sequencing
technology, with its characteristics of large data volume,
low cost and fast speed, has made a qualitative leap in
the study of intestinal microbial metagenomics. It can
more accurately and deeply analyze the microbial
structure, composition, gene function, metabolic pathway
and the impact of drugs on intestinal microorganisms.
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